The New York Times – Business:
The Baltimore plant that recently had to scrap up to 15 million ruined doses had flouted rules and downplayed errors, according to internal audits, ex-employees and clients. Other doses had to be scrapped last year.
Author: RSS Feed
This post first appeared in The New York Times – Business. Read the original article.